Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
| Agenus to Present at Two Healthcare Investor Conferences In September | ||
| By: PR Newswire Association LLC. - 19 Sep 2017 | Back to overview list |
|
LEXINGTON, Mass., Sept. 19, 2017 /PRNewswire/ -- Agenus Inc. (NASDAQ: AGEN), an immune-oncology company with a pipeline of immune checkpoint antibodies and cancer vaccines, announced today that members of the Company's Leadership will present and host one-on-one meetings at two healthcare investment conferences in September. The details for the conferences are:
A live audio webcast will be available on the "Events & Presentations" section of the Company's investor website at www.agenusbio.com where a replay will also be available following the presentation. About Agenus Agenus is a clinical-stage immuno-oncology company focused on the discovery and development of therapies that engage the body's immune system to fight cancer. The Company's vision is to expand the patient populations benefiting from cancer immunotherapy by pursuing a number of combination approaches that leverage a broad repertoire of antibody therapeutics and proprietary cancer vaccine platforms. The Company is equipped with a suite of antibody discovery platforms and a state-of-the-art GMP manufacturing facility with the capacity to support early phase clinical programs. Agenus is headquartered in Lexington, MA. For more information, please visit www.agenusbio.com; information that may be important to investors will be routinely posted on our website. Contact: Agenus Inc.
View original content with multimedia:http://www.prnewswire.com/news-releases/agenus-to-present-at-two-healthcare-investor-conferences-in-september-300521712.html SOURCE Agenus Inc. 
|
||
|
||
 | Back to overview list | |